“Many factors clearly play a role in the development of Parkinson’s disease, including environmental factors,” said study author Chia-Hung Kao, MD, China Medical University in Taichung, Taiwan. “This nation-wide study, using the National Health Insurance Research Database of Taiwan, suggests that hepatitis caused specifically by the hepatitis C virus may increase the risk of developing the disease. More research is needed to investigate this link.”
The World Health Organization estimates that 130 to 150 million people have hepatitis C worldwide. While hepatitis C can lead to serious illness, many people have few symptoms and do not realize they have the virus, especially at first.
The virus is transmitted through sharing needles, needle stick injuries in health care providers and passed on at birth from infected mothers. In Taiwan during the time of the study, blood transfusions were the most common cause of the virus. In the United States, all donated blood has been screened for the virus since 1992.
The study involved 49,967 people with hepatitis and 199,868 people without hepatitis. Participants with hepatitis were placed into three groups: those infected with the hepatitis B virus (71 percent), those with hepatitis C (21 percent), and those who had both viruses (8 percent).
The participants were followed for an average of 12 years to see who developed Parkinson’s disease. Of those with hepatitis, 270 developed Parkinson’s disease, including 120 people with hepatitis C. Among those who did not have hepatitis, 1,060 developed Parkinson’s disease.
Once researchers controlled for factors such as age, sex, diabetes and cirrhosis, they found that people with hepatitis C were nearly 30 percent more likely to develop Parkinson’s disease than the people who did not have hepatitis.
People with hepatitis B and those with both viruses were not more or less likely to develop Parkinson’s than those who did not have hepatitis.
This study was supported by the Taiwan Ministry of Health and Welfare, China Medical University Hospital, Academia Sinica Taiwan Biobank, Stroke Biosignature Project, NRPB Stroke Clinical Trial Consortium, Tseng-Lien Lin Foundation, Taiwan Brain Disease Foundation, Katsuzo and Kiyo Aoshima Memorial Funds and CMU under the Aim for Top University Plan of the Ministry of Education.
To learn more about Parkinson’s disease, visit http://www.aan.com/patients.
The American Academy of Neurology, an association of more than 30,000 neurologists and neuroscience professionals, is dedicated to promoting the highest quality patient-centered neurologic care. A neurologist is a doctor with specialized training in diagnosing, treating and managing disorders of the brain and nervous system such as Alzheimer’s disease, stroke, migraine, multiple sclerosis, concussion, Parkinson’s disease and epilepsy.